Khalid Al-Baimani

454 total citations
29 papers, 233 citations indexed

About

Khalid Al-Baimani is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Khalid Al-Baimani has authored 29 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 14 papers in Oncology and 8 papers in Epidemiology. Recurrent topics in Khalid Al-Baimani's work include Lung Cancer Treatments and Mutations (6 papers), Global Cancer Incidence and Screening (4 papers) and Lung Cancer Research Studies (4 papers). Khalid Al-Baimani is often cited by papers focused on Lung Cancer Treatments and Mutations (6 papers), Global Cancer Incidence and Screening (4 papers) and Lung Cancer Research Studies (4 papers). Khalid Al-Baimani collaborates with scholars based in Oman, Canada and United Kingdom. Khalid Al-Baimani's co-authors include Paul Wheatley‐Price, Garth Nicholas, Scott A. Laurie, Tinghua Zhang, Mark Clemons, Susan J. Robertson, Christina Addison, Stephanie Yasmin Brule, Glenwood D. Goss and Glenwood Goss and has published in prestigious journals such as Journal of Clinical Oncology, BMJ Open and Lung Cancer.

In The Last Decade

Khalid Al-Baimani

21 papers receiving 226 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Khalid Al-Baimani Oman 8 127 111 42 40 30 29 233
Akina Natori United States 9 133 1.0× 70 0.6× 40 1.0× 39 1.0× 22 0.7× 30 257
Elena Orlandi Italy 11 136 1.1× 108 1.0× 34 0.8× 43 1.1× 29 1.0× 29 249
Erin M. Bange United States 7 115 0.9× 51 0.5× 24 0.6× 41 1.0× 16 0.5× 21 198
Hagar Elghazawy Egypt 9 182 1.4× 60 0.5× 31 0.7× 18 0.5× 23 0.8× 19 284
Mike Sung Canada 7 234 1.8× 149 1.3× 54 1.3× 37 0.9× 24 0.8× 18 318
Christopher Su United States 11 149 1.2× 114 1.0× 23 0.5× 41 1.0× 45 1.5× 30 297
Joonas Miettinen Finland 6 117 0.9× 57 0.5× 14 0.3× 34 0.8× 38 1.3× 12 224
Vittorio Gebbia Italy 8 148 1.2× 63 0.6× 39 0.9× 16 0.4× 19 0.6× 46 241
Saira Khan United States 11 100 0.8× 102 0.9× 29 0.7× 37 0.9× 29 1.0× 43 325
Caroleen Quach United States 8 188 1.5× 70 0.6× 19 0.5× 20 0.5× 28 0.9× 13 342

Countries citing papers authored by Khalid Al-Baimani

Since Specialization
Citations

This map shows the geographic impact of Khalid Al-Baimani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalid Al-Baimani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalid Al-Baimani more than expected).

Fields of papers citing papers by Khalid Al-Baimani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalid Al-Baimani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalid Al-Baimani. The network helps show where Khalid Al-Baimani may publish in the future.

Co-authorship network of co-authors of Khalid Al-Baimani

This figure shows the co-authorship network connecting the top 25 collaborators of Khalid Al-Baimani. A scholar is included among the top collaborators of Khalid Al-Baimani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalid Al-Baimani. Khalid Al-Baimani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ibrahim, Rawan, et al.. (2025). Enhancing Medication Safety: Reducing Administration Errors in Oncology Setting. Asian Pacific Journal of Cancer Prevention. 26(1). 269–277.
2.
Al-Baimani, Khalid, et al.. (2025). Cytomegalovirus and Epstein-Barr Virus reactivation in steroid-refractory immune checkpoint inhibitor colitis. The Journal of Infection in Developing Countries. 19(8). 1276–1282.
3.
Usmani, Sharjeel, et al.. (2024). Enhancing precision in bone metastasis diagnosis for lobular breast cancer: reassessing the role of 18F-FDG PET/CT. Nuclear Medicine Communications. 45(10). 858–864. 2 indexed citations
4.
5.
Ibrahim, Rawan, et al.. (2024). Assessing Health Literacy, Learning Needs, and Patient Satisfaction in Cancer Care: A Holistic Study in the Omani Context. Asian Pacific Journal of Cancer Biology. 9(4). 553–560.
6.
Al‐Sayegh, Hasan, et al.. (2024). Predominance of Candida glabrata in candidemia among patients with solid tumor cancer in Oman: A retrospective study. IJID Regions. 12. 100389–100389. 3 indexed citations
7.
Jayakrishnan, B, et al.. (2022). Pulmonary Toxicities of Immune Check Point Inhibitors in the Management of Cancer: Mini Review. Advances in respiratory medicine. 90(3). 219–229. 3 indexed citations
8.
9.
Kumar, Shiyam, et al.. (2021). Beliefs and Perceptions About Cancer Diagnosis and Treatment-Seeking and Decision-Making Behaviors Among Omani Patients with Cancer: A Single-Center Study. Journal of Religion and Health. 61(2). 1351–1365. 7 indexed citations
10.
Al‐Azri, Mohammed, et al.. (2021). The Unmet Supportive Care Needs of Omani Women Diagnosed with Breast Cancer. Sultan Qaboos University medical journal. 22(4). 515–524. 5 indexed citations
11.
Lakhtakia, Ritu, et al.. (2021). Correlation of expression of Akt1 and E2F1 and their phosphorylated forms in breast cancer patients with clinicopathological parameters. Journal of Molecular Histology. 52(3). 621–633. 4 indexed citations
12.
Kumar, Shiyam, et al.. (2021). Complications and Management of Totally Implantable Central Venous Access Ports in Cancer Patients at a University Hospital in Oman. Sultan Qaboos University medical journal. 21(1). e103–109. 13 indexed citations
13.
Kumar, Shiyam, et al.. (2019). Outcomes of Women with Non-Metastatic Triple-Negative Breast Cancer in Oman: A single-centre experience. Sultan Qaboos University medical journal. 19(3). e209–216. 3 indexed citations
14.
Kumar, Shiyam, et al.. (2019). Outcome of Omani Women with Breast Cancer-associated Brain Metastases Experience from a University Hospital. Oman Medical Journal. 34(5). 412–419. 5 indexed citations
15.
Al-Baimani, Khalid, et al.. (2018). Are Clinical Trial Eligibility Criteria an Accurate Reflection of a Real-World Population of Advanced Non-Small-Cell Lung Cancer Patients?. Current Oncology. 25(4). 291–297. 34 indexed citations
16.
Al-Baimani, Khalid, et al.. (2018). Knowledge and Attitudes Towards Clinical Trial Participation in Oman: A cross-sectional study. Sultan Qaboos University medical journal. 18(1). e54–60. 13 indexed citations
17.
McGee, Sharon F., Tinghua Zhang, Scott A. Laurie, et al.. (2017). The Impact of Baseline Edmonton Symptom Assessment Scale Scores on Treatment and Survival in Patients With Advanced Non–small-cell Lung Cancer. Clinical Lung Cancer. 19(1). e91–e99. 22 indexed citations
18.
Dudani, Shaan, Sasha Mazzarello, John Hilton, et al.. (2016). Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients—A Systematic Review. Clinical Breast Cancer. 16(6). 456–470. 22 indexed citations
19.
Brule, Stephanie Yasmin, Khalid Al-Baimani, Tinghua Zhang, et al.. (2016). Palliative systemic therapy for advanced non-small cell lung cancer: Investigating disparities between patients who are treated versus those who are not. Lung Cancer. 97. 15–21. 39 indexed citations
20.
Al-Baimani, Khalid, Harman Sekhon, & Paul Wheatley‐Price. (2015). Recurrence of anaplastic lymphoma kinase (ALK) positive adenocarcinoma after 17 years: Case report. 4. 6–9. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Akina Natori Breakdown of academic impact, for papers by Elena Orlandi Breakdown of academic impact, for papers by Erin M. Bange Breakdown of academic impact, for papers by Hagar Elghazawy Breakdown of academic impact, for papers by Mike Sung Breakdown of academic impact, for papers by Christopher Su Breakdown of academic impact, for papers by Joonas Miettinen Breakdown of academic impact, for papers by Vittorio Gebbia Breakdown of academic impact, for papers by Saira Khan Breakdown of academic impact, for papers by Caroleen Quach
Rankless by CCL
2026